ANGPT2 and small cell lung carcinoma: ITGB1-KO itself had no proliferation disadvantage in SCLC cells (Supplemental Figure 9C) but hindered migration and invasion upon fibronectin and ANG-2–dependent stimulation (Supplemental Figure 9, D and E, and Supplemental Figure 10).